| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
GreenLight Biosciences (NASDAQ:GRNA) reported its Q1 earnings results on Thursday, May 11, 2023 at 07:00 AM.
Here's what investors need to know about the announcement.
GreenLight Biosciences beat estimated earnings by 17.39%, reporting an EPS of $-0.19 versus an estimate of $-0.23.
Revenue was up $3.56 million from the same period last year.
Last quarter the company missed on EPS by $0.01 which was followed by a 3.55% increase in the share price the next day.
Listen to the earnings announcement yourself by clicking here.
To track all earnings releases for GreenLight Biosciences visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: GRNA
